Added value of amyloid PET in individualized risk predictions for MCI patients

Added value of amyloid PET in individualized risk predictions for MCI patients

Abstract Introduction To construct a prognostic model based on amyloid positron emission tomography (PET) to predict clinical progression in individual patients with mild cognitive impairment (MCI). Methods We included 411 MCI patients from the Alzheimer's Disease Neuroimaging Initiative. Progn...

Full description

Bibliographic Details
Main Authors: Ingrid S. vanMaurik, Laura M. van derKall, Arno deWilde, Femke H. Bouwman, Philip Scheltens, Bart N.M. vanBerckel, Johannes Berkhof, Wiesje M. van derFlier, Alzheimer's Disease Neuroimaging Initiative
Format: Article
Language:English
Published: Wiley 2019-12-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Biomarkers
Amyloid positron emission tomography
MCI
Progression
Alzheimer's disease
Online Access:https://doi.org/10.1016/j.dadm.2019.04.011

Internet

https://doi.org/10.1016/j.dadm.2019.04.011

Similar Items